ESC 365 - Use of GDF-15 in the management of patients with ACS.

Open Access

Use of GDF-15 in the management of patients with ACS.

Session: How to use biomarkers to optimize diagnosis and risk stratification of acute coronary syndrome (ACS)

Topic: Infarction acute phase STEMI

Speaker: Professor L. Wallentin (Uppsala, SE)

Sponsored by Roche Diagnostics International

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Professor Lars Wallentin

Uppsala University, Uppsala (Sweden)

18 presentations

1 follower

3 more presentations in this session

Introduction - How to use biomarkers to optimize diagnosis and risk stratification of ACS.

Speaker: Professor H. Katus (Heidelberg, DE) Professor C. Mueller (Basel, CH)

Benefits of the 1-hour algorithm for the diagnosis of acute myocardial infarction (AMI) using cardiac troponin T -high sensitive.

Speaker: Professor C. Mueller (Basel, CH)

Do cardiac troponin T -high sensitive gender specific cut-offs lead to different treatment strategy for the diagnosis of AMI?

Speaker: Assistant Professor E. Giannitsis (Heidelberg, DE)

Access the full session

How to use biomarkers to optimize diagnosis and risk stratification of acute coronary syndrome (ACS)

Speakers: Professor L. Wallentin, Professor H. Katus, Professor C. Mueller, Professor C. Mueller, Assistant Professor E. Giannitsis

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources